Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Merger with Manipal...

    Merger with Manipal expected to be completed in 1 year: Fortis

    Written by Ruby Khatun Khatun Published On 2018-03-29T10:45:25+05:30  |  Updated On 29 March 2018 10:45 AM IST
    Merger with Manipal expected to be completed in 1 year: Fortis




    New Delhi: Fortis Healthcare Ltd (FHL) said the merger of its hospitals business into Manipal Hospitals Enterprises is expected to be completed in 10-12 months.

    The company's board had yesterday approved demerger of its hospitals business, which will be acquired by Manipal Hospitals and TPG Capital, along with the sale of 20 percent stake in diagnostics chain SRL Ltd.

    "The merger will take time. The merging of Fortis into Manipal will take between 10 to 12 months," FHL CEO Bhavdeep Singh said in a conference call today.

    The company had said yesterday that the proposed transaction was subject to shareholders' approval, creditors' approval, applicable regulatory approvals (including Competition Commission of India, SEBI, stock exchanges and National Company Law Tribunal (NCLT) and other customary conditions precedent.

    When asked about the investigations by Serious Fraud Investigation Office (SFIO) in the company over alleged financial irregularities in the company involving its promoters, Singh brothers, Bhavdeep Singh said: "We are cooperating with the ongoing SFIO investigations."

    The sale of the hospital business of Fortis to Manipal-TPG combine comes at a time when the Singh brothers -- Malvinder and Shivinder -- are facing intense pressure over alleged financial irregularities at Fortis and Religare, which the SFIO is investigating.

    Both Malvinder Singh and Shivinder Singh had quit from the boards of Fortis and Religare last month.

    The Delhi High Court had on January 31 upheld an international arbitral award of Rs 3,500 crore passed in favour of Japanese pharma major Daiichi Sankyo, which had alleged that the former promoters of erstwhile Ranbaxy Laboratories had concealed information about proceedings against them by the US Food and Drug Administration.

    Moreover, on February 15, the Supreme Court lifted its stay on sale of shares of Fortis Healthcare Ltd. pledged with banks by the Singh brothers before August 31, allowing financial institutions, including Axis Bank and Yes Bank, to sell the pledged shares.

    Shares of Fortis Healthcare tanked 9.58 percent in the afternoon trade at Rs 128.80 apiece on BSE reacting to the news of the sale of its hospitals business.

    As part of the transaction, Fortis board had also approved the sale of 20 percent stake in diagnostics chain SRL Ltd.

    Manipal Hospitals, part of Manipal Education and Medical Group (MEMG), is owned by Dr Ranjan Pai and has been backed by TPG, a leading global alternative asset firm and experienced healthcare investor since 2015.

    As part of the proposed transaction, Ranjan Pai and TPG will invest Rs 3,900 crore into the merged entity.

    The combined entity will have pan India presence with 45 hospitals and a bed capacity of over 7,658 beds. It will have over 4,200 doctors, more than 9,300 nurses and 11,400-plus other employees across India.




    Bhavdeep Singhdiagnostics chainFortisFortis Healthcare LtdManipalManipal HospitalsmergerNational Company Law TribunalSRL LtdTPG capital
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok